Statements of Cash Flows (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash Flows from Operating Activities:
Net Income	$ 10,256,362	$ 6,875,073
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,421,177	2,230,250
Abandoned patents written off	66,619	76,231
Provision for bad debts	1,544,521	1,050,442
Deferred income tax benefit - net	(2,473,892)
Gain on sale of equipment	(557,473)
Gain on litigation settlement	(755,500)
Impairment on management agreement	357,500
Compensatory element of stock issuances	415,021	180,418
Stock issued for costs and expenses		427,558
(Increase) decrease in operating assets, net:
Accounts, management fee and medical receivable(s)	(3,717,440)	(996,720)
Notes receivable	120,976	80,845
Costs and estimated earnings in excess of Billings on uncompleted contracts	682,854	(959,153)
Inventories	117,861	205,291
Prepaid expenses and other current assets	(698,284)	174,754
Other assets	(204,037)	108,054
Increase (decrease) in operating liabilities, net:
Accounts payable	628,033	(164,669)
Other current liabilities	(414,402)	(830,644)
Customer advances	(567,914)	(964,510)
Billings in excess of costs and estimated earnings on uncompleted contracts	142,217	(4,045)
Other liabilities	253,559	(101,304)
Due to related medical practices	1,885	474
Income tax payable	(80,499)	25,000
NET CASH PROVIDED BY OPERATING ACTIVITIES	7,539,144	7,413,345
Cash Flows from Investing Activities:
Purchases of property and equipment	(1,135,382)	(1,081,209)
Cost of acquisition	(40,000,000)
Cost of patents	(159,907)	(146,163)
NET CASH USED IN INVESTING ACTIVITIES	(41,295,289)	(1,227,372)
Cash Flows from Financing Activities
Proceeds from debt	14,689,646	246,000
Proceeds from sale of equipment	700,000
Repayment of borrowings and capital lease obligations	(1,821,617)	(1,387,225)
Repayment of notes receivable from employee stockholders	15,993	44,492
Distributions to non controlling interests	(1,799,950)	(1,135,000)
Redemption of Non-Controling Interests	(1,424,900)	(1,200,000)
Buyout of Non Controling Interest	(564,315)
Proceeds from non controlling interest	19,800,000	16,031
Sale to non controlling interest		10,500
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	29,594,857	(3,405,202)
Net Increase in Cash and Cash Equivalents	(4,161,288)	2,780,771
Cash and Cash Equivalents Beginning of Year	12,032,015	9,251,244
Cash and Cash Equivalents - End of Year	$ 7,870,727	$ 12,032,015